Surprisingly, despite the widespread use of PSMA as a target for PCa imaging and therapy, the role and/or benefit of PSMA overexpression in PCa cells is still poorly understood and the importance of PSMA carboxypeptidase activity for PCa progression is debatable (13–16). Here, FOLH1 is linked to posterior cortical atrophy.